Filtered By:
Source: International Journal of Cardiology
Condition: Atrial Fibrillation
This page shows you your search results in order of relevance. This is page number 14.
Order by Relevance | Date
Total 388 results found since Jan 2013.
Leukoaraiosis and ambulatory blood pressure load in a healthy elderly cohort study: The PROOF study
Abstract: Background: Old age and hypertension are consistently reported to be the main risk factors of leukoaraiosis. The association between white matter lesions (WMLs) and other cardiovascular risk factors (CVRF) remains controversial. We evaluated the association between CVRF and WMLs in a cohort study and determined the blood pressure variables that could predict WML severity.Methods: 830 subjects (65+/−1years of age, 60% women) from the PROOF study, with a reliable ABPM and brain MRI, were included. The exclusion criteria included prior myocardial infarction, stroke, heart failure, atrial fibrillation, type 1 diabe...
Source: International Journal of Cardiology - February 4, 2014 Category: Cardiology Authors: John Avet, Vincent Pichot, Jean-Claude Barthélémy, Bernard Laurent, Arnauld Garcin, Frédéric Roche, Sébastien Celle Tags: Original Articles Source Type: research
Successful management of a twice complicated case by implantation of three CoreValve prostheses
An 80year old man, diabetic on oral medication and with permanent atrial fibrillation with a single chamber pacemaker, was referred to our hospital for severe symptomatic aortic valve stenosis. His trans-thoracic echocardiography confirmed severe aortic stenosis with a mean/peak gradient of 45/85mmHg, an estimated aortic valve area of 0.7cm2 and good systolic function with an ejection fraction of 50%. His past medical history was remarkable for a minor stroke without neurological impairment and moderate kidney dysfunction with creatinine of 2.3mg/dL. A cardiac catheterization revealed no obstructive coronary heart disease.
Source: International Journal of Cardiology - January 27, 2014 Category: Cardiology Authors: George Latsios, Kostantinos Toutouzas, Dimitris Tousoulis, Andreas Synetos, Antonios Mastrokostopoulos, Konstantinos Stathogiannis, Themis Spyridopoulos, Ulrich Gerckens, Christodoulos Stefanadis Tags: Letters to the Editor Source Type: research
Non-standard dose dronedarone in treating atrial fibrillation patients
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia requiring medical care . Dronedarone is derived from amiodarone, but has different electrophysiological effects . Dronedarone has been approved to treat paroxysmal or persistent AF, which is associated with a reduction of AF-related hospitalization, stroke or mortality . However, dronedarone should be avoided in patients with decompensated heart failure or permanent AF due to an increased mortality .
Source: International Journal of Cardiology - January 23, 2014 Category: Cardiology Authors: Jen-Hung Huang, Yung-Kuo Lin, Ming-Hsiung Hsieh, Shih-Ann Chen, Yi-Jen Chen Tags: Online Letters to the Editor Source Type: research
Prevalence of patent foramen ovale in atrial fibrillation patients with history of cerebral ischemia: A stand-alone additional risk?
Patent foramen ovale (PFO) is generally found in about 20–25% of the general population. The marked association between cryptogenic stroke/TIA and PFO supports the hypothesis that paradoxical embolism could be a major cause . The prevalence of foramen patency gradually decreases with age and probably also with conditions which can increase left atrial filling pressures .
Source: International Journal of Cardiology - January 21, 2014 Category: Cardiology Authors: Franco Zoppo, Giuseppe Stabile, Alessia Pappone, Andrea Avella, Domenico Pecora, Leonardo Corò, Gianluca Zingarini, Roberto Verlato, Antonello Castro, Emanuele Bertaglia Tags: Online Letters to the Editor Source Type: research
Patent foramen ovale, transient ischemic attack and Kounis syndrome
In their important meta-analysis of Ntaios et al.'s study published in this Journal , concerning all randomized control trials of patent foramen ovale closure versus medical treatment, the authors found no benefit in the prevention of cryptogenic shock and transient ischemic attack with implantation of unselected devices. However, in a subgroup analysis, selected closure devices may be superior to medical therapy without increasing the risk of new-onset atrial fibrillation. Indeed, in the CLOSURE trial the rate of stroke, transient ischemic attack, or death did not diminish and the risks of major vascular events and atrial...
Source: International Journal of Cardiology - January 23, 2014 Category: Cardiology Authors: George D. Soufras, Nicholas G. Kounis Tags: Online Letters to the Editor Source Type: research
Prevalence and prognostic implications of different types of atrial fibrillation in patients admitted to a coronary care unit
The objective of the present study was to investigate the prevalence of AF, its prognostic implications in terms of the development of new ischemic stroke, and the all-cause mortality associated with different types of AF in a non-surgical CCU.
Source: International Journal of Cardiology - January 27, 2014 Category: Cardiology Authors: Héctor González-Pacheco, Guering Eid-Lidt, Alfredo Altamirano-Castillo, Amada Álvarez-Sangabriel, Antonio González-Hermosillo, Gabriela Meléndez-Ramírez, José Luis Briseño-Cruz, Manuel Galván-Carrasco, Sol Ordaz-Soto, Carlos Martínez-Sánchez Tags: Online Letters to the Editor Source Type: research
Association of Left Superior Vena Cava, Sinus Venosus Defect and partial anomalous pulmonary venous return: An echographic and MDCT study
An 83 years old man with a medical history of paroxysmal atrial fibrillation and transient ischemic stroke was referred to our echography laboratory for etiologic evaluation of a NYHA 2 dyspnea. Trans-thoracic echocardiography found enlarged right cavities (end-diastolic right ventricle (RV) diameter=54mm right atrium (RA) area=27cm2, RV outflow tract=40mm and pulmonary artery (PA)=29mm), associated with a large coronary sinus (). RV systolic function was preserved. PA pressure was high (systolic pulmonary artery pressure=60mmHg). Inter atrial septum seemed intact. Pulmonary to systemic flow ratio (QP/QS) was calculated as...
Source: International Journal of Cardiology - January 21, 2014 Category: Cardiology Authors: Nicolas Baron Tags: Online Letters to the Editor Source Type: research
Clinical characteristics of atrial fibrillation detected by implanted devices and its association with ICD therapy
Detection of atrial fibrillation (AF) by cardiac devices (CD) has high sensitivity and is useful in clinical situation. It was reported that subclinical atrial fibrillation detected by implanted devices were associated with an increased risk of ischemic stroke or systemic embolism . ICD shocks are associated with adverse survival outcome. However the association between AF and ICD shocks was not fully understood.
Source: International Journal of Cardiology - February 3, 2014 Category: Cardiology Authors: Yoshiyasu Aizawa, Seiji Takatsuki, Masachika Negishi, Shin Kashimura, Yoshinori Katsumata, Takahiko Nishiyama, Takehiro Kimura, Nobuhiro Nishiyama, Yoko Tanimoto, Kojiro Tanimoto, Shun Kohsaka, Motoaki Sano, Keiichi Fukuda Tags: Online Letters to the Editor Source Type: research
Efficacy of new oral anticoagulants in patients with atrial fibrillation previously treated with warfarin: A meta-analysis of randomized controlled trials
Vitamin K antagonists (VKAs), together with newer oral anticoagulants (NOACs) such as dabigatran, rivaroxaban, or apixaban, reduce the risk of stroke in patients with atrial fibrillation (AF). However, patients with no prior exposure to anticoagulation (i.e., VKA naive) may be at higher risk for adverse outcomes (thromboembolic events and/or bleeding) than patients who are VKA experienced. When adjusted-dose VKA (INR 2–3) cannot be used in a patient with AF where an oral anticoagulant (OAC) is recommended, due to difficulties in keeping INR within therapeutic range of 2 to 3, experiencing side effects of VKAs, or inabili...
Source: International Journal of Cardiology - March 13, 2014 Category: Cardiology Authors: Laurent Fauchier, Nicolas Clementy, Christophe Saint-Etienne, Edouard Simeon, Denis Angoulvant, Anne Bernard-Brunet Tags: Letters to the Editor Source Type: research
Dual antiplatelet therapy versus warfarin anticoagulation in patients undergoing catheter ablation of atrial fibrillation
Radio frequency catheter ablation (RFCA) has become a standard treatment for patients with atrial fibrillation (AF) . Anticoagulation in patients undergoing AF ablation is crucial to minimize the risk of thromboembolic complications. Although warfarin is effective in reducing stroke, its chronic use has many disadvantages including frequent international normalized ratio (INR)/prothrombin, attention to numerous dietary and medication interactions, and risk of serious bleeding including intracranial hemorrhage . Novel oral anticoagulants provide a reasonable alternative; however, they cannot yet be reversed, are expensive, ...
Source: International Journal of Cardiology - March 28, 2014 Category: Cardiology Authors: Zhiyu Ling, Fengpeng Jia, Yanping Xu, Li Su, Zengzhang Liu, Huaan Du, Xiaoyu Yang, Xianbin Lan, Peilin Xiao, Weijie Chen, Jinqi Fan, Suxin Luo, Yuehui Yin, Saman Nazarian Tags: Letters to the Editor Source Type: research
The predictive value of CHADS2 risk score in post myocardial infarction arrhythmias — A Cardiac Arrhythmias and RIsk Stratification after Myocardial infArction (CARISMA) substudy
Abstract: Background: Previous studies have shown substantially increased risk of cardiac arrhythmias and sudden cardiac death in post-myocardial infarction (MI) patients. However it remains difficult to identify the patients who are at highest risk of arrhythmias in the post-MI setting. The purpose of this study was to investigate if CHADS2 score (congestive heart failure, hypertension, age ≥75years, diabetes and previous stroke/TCI [doubled]) can be used as a risk tool for predicting cardiac arrhythmias after MI.Methods: The study included 297 post-MI patients from the CARISMA study with left ventricular ejection fract...
Source: International Journal of Cardiology - April 7, 2014 Category: Cardiology Authors: Anne Christine Ruwald, Uffe Gang, Poul Erik Bloch Thomsen, Rikke Mørch Jørgensen, Martin H. Ruwald, Heikki V. Huikuri, Christian Jons Tags: Original Articles Source Type: research
The use of direct oral anticoagulants for stroke prevention in atrial fibrillation: A study on physicians' perspective and preferences
Source: International Journal of Cardiology - April 28, 2014 Category: Cardiology Authors: Alexander Wutzler, Marwin Bannehr, Ann Cathrin Pöhlmann, Wilhelm Haverkamp Source Type: research
Pharmacology, benefits, unaddressed questions, and pragmatic issues of the newer oral anticoagulants for stroke prophylaxis in non-valvular atrial fibrillation and proposal of a management algorithm
Source: International Journal of Cardiology - April 26, 2014 Category: Cardiology Authors: Salvatore Rosanio, Abdul M. Keylani, Darrin C. D'Agostino, Craig M. DeLaughter, Antonio Vitarelli Source Type: research
Short stature and ischemic stroke in nonvalvular atrial fibrillation: New insight into the old observation
Source: International Journal of Cardiology - April 21, 2014 Category: Cardiology Authors: Jeonggeun Moon, Hye-Jeong Lee, Young Jin Kim, Jong-Youn Kim, Hui-Nam Pak, Jong-Won Ha, Moon-Hyoung Lee, Boyoung Joung Source Type: research
The use of direct oral anticoagulants for stroke prevention in atrial fibrillation: A study on physicians' perspective and preferences
Source: International Journal of Cardiology - April 28, 2014 Category: Cardiology Authors: Alexander Wutzler, Marwin Bannehr, Ann Cathrin Pöhlmann, Wilhelm Haverkamp Source Type: research
